A detailed history of Senator Investment Group LP transactions in Novo Nordisk A S stock. As of the latest transaction made, Senator Investment Group LP holds 150,000 shares of NVO stock, worth $21.4 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares
150,000
Previous 10,000 1400.0%
Holding current value
$21.4 Million
Previous $1.03 Million 1762.67%
% of portfolio
0.9%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$102.11 - $135.92 $14.3 Million - $19 Million
140,000 Added 1400.0%
150,000 $19.3 Million
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $877,800 - $1.05 Million
10,000 New
10,000 $1.03 Million
Q1 2023

May 12, 2023

BUY
$132.34 - $159.14 $29.8 Million - $35.8 Million
225,000 Added 112.5%
425,000 $67.6 Million
Q4 2022

Feb 13, 2023

BUY
$102.55 - $135.33 $20.5 Million - $27.1 Million
200,000 New
200,000 $27.1 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $322B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Senator Investment Group LP Portfolio

Follow Senator Investment Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Senator Investment Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Senator Investment Group LP with notifications on news.